Skip to content

Avanos Medical AVNS Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$4.54M-12.8%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
-$4.13M-140%
IAR
Integra LifeSciencesIART
$21.88M+24.6%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
-$1.23M+95.7%
Novanta logo
NovantaNOVT
$317.25K-14.9%
Baxter International logo
Baxter InternationalBAX

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's increase (decrease) in prepaid expense and other assets?
Avanos Medical (AVNS) reported increase (decrease) in prepaid expense and other assets of $2.4M in Q1 2026.
How has Avanos Medical's increase (decrease) in prepaid expense and other assets changed year-over-year?
Avanos Medical's increase (decrease) in prepaid expense and other assets increased by 900.0% year-over-year, from -$300K to $2.4M.
What is the long-term trend for Avanos Medical's increase (decrease) in prepaid expense and other assets?
Over 3 years (2021 to 2025), Avanos Medical's increase (decrease) in prepaid expense and other assets has grown at a -9.7% compound annual growth rate (CAGR), from $1.9M to -$1.4M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.